Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D for Hyperprolinemia-Associated Schizophrenia
NCT02197286Phase 2Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Feb 2015
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in schizophrenia, schizoaffective disorder, sponsored by NYU Langone Health. Planned start Feb 2015; status: withdrawn.
02
Drugs
vitamin d
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02197286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02197286.